NAMS 2023 Annual Meeting
The Menopause Society
Annual Meeting 2023
This program was supported by Astellas Pharma.
conference highlights
AUDIO & VIDEO CAPSULES
Abstract Summaries
Dr. Kelsey Mills
Watch video capsule
Abstract Summaries
Dr. Céline Bouchard
Effect of Fezolinetant on Moderate-to-Severe Vasomotor Symptoms in Subgroups Based on Hormone Therapy History: Pooled Data from Two Randomized Phase 3 Studies
Watch video capsule
Abstract Summaries
Dr. Céline Bouchard
Treatment Satisfaction Among Women with Moderate to Severe Vasomotor Symptoms (VMS) Due to Menopause and Physicians Who Treat Women with VMS in the United States
Watch video capsule
Abstract Summaries
Dr. Ardelle Piper
The Female Aging Brain:
What Do We Know About Alzheimer Prevention?
Ovarian Hormones and Cognitive Health: The Past and the Future
Watch video capsule
This program was supported by Astellas Pharma. Statements of fact and opinions expressed are those of the speakers and do not necessarily reflect the opinions or position of Astellas Pharma.
The contents of this site may contain information regarding indications and/or instructions which differ from the approved use of products available in Canada. For complete information, please refer to the respective product monographs available through the manufacturer’s website. The safety and efficacy of some of the products described herein are still under investigation and have not received market authorization from Health Canada.
This website is intended for Canadian healthcare professionals.